Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale

International Journal of Experimental Pathology

Volumn 96, Issue 1, 2015, Pages 11-20

  Pasqualetti, Sara ^a   Congiu, Terenzio ^b   Banfi, Giuseppe ^c,d   Mariotti, Massimo ^c,e  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone matrix; Glucocorticoid induced osteoporosis; Scale; Zebrafish

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALENDRONIC ACID; ALKALINE PHOSPHATASE; GLUCOCORTICOID; PREDNISOLONE; ACID PHOSPHATASE; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE; ZEBRAFISH PROTEIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BONE MINERALIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GLUCOCORTICOID INDUCED OSTEOPOROSIS; HUMAN; MINERAL BALANCE; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; TREATMENT OUTCOME; ZEBRA FISH; ANIMAL; BONE MATRIX; BONE REMODELING; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; MALE; METABOLISM; OSTEOCLAST; TIME FACTOR; TISSUE CULTURE TECHNIQUE;

ACID PHOSPHATASE; ALENDRONATE; ALKALINE PHOSPHATASE; ANIMALS; BIOMARKERS; BONE DENSITY CONSERVATION AGENTS; BONE MATRIX; BONE REMODELING; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; ISOENZYMES; MALE; OSTEOCLASTS; OSTEOPOROSIS; PHENOTYPE; PREDNISOLONE; TIME FACTORS; TISSUE CULTURE TECHNIQUES; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84923422505     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12106     Document Type: Article

References (33)

1. Baofeng L., Zhi Y., Bei C. et al. (2010) Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid. Acta Orthop. 81, 396-401.
2. Barrett R., Chappell C., Quick M. et al. (2006) A rapid, high content, in vivo model of glucocorticoid-induced osteoporosis. Biotechnol. J. 1, 651-655.
3. Chavassieux P., Pastoureau P., Chapuy M.C. et al. (1993) Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study. Osteoporos. Int. 3, 97-102.
4. Chavassieux P., Buffet A., Vergnaud P. et al. (1997) Short-term effects of corticosteroids on trabecular bone remodelling in old ewes. Bone 20, 451-455.
5. Congiu T., Radice R., Raspanti M. et al. (2004) The 3D structure of the human urinary bladder mucosa. A scanning electron microscopy study. J. Submicrosc. Cytol. Pathol. 36, 45-53.
6. de Vrieze E., Sharif F., Metz J.R. et al. (2011) Matrix metalloproteinases in osteoclasts of ontogenetic and regenerating zebrafish scales. Bone 48, 704-712.
7. de Vrieze E., van Kessel M.A., Peters H.M. et al. (2014a) Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales. Osteoporos. Int. 25, 567-578.
8. de Vrieze E., Moren M., Metz J.R. et al. (2014b) Arachidonic acid enhances turnover of the dermal skeleton: studies on zebrafish scales. PLoS ONE 9, e89347.
9. Hofbauer L.C., Gori F., Riggs B.L. et al. (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanism of glucocorticoids-induced osteoporosis. Endocrinology 140, 4382-4389.
10. Hofbauer L.C., Zeitz U., Schoppet M. et al. (2009) Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum. 60, 1427-1437.
11. Kim H.J., Zhao H., Kitaura H. et al. (2006) Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116, 2152-2160.
12. Kimmel C.B., DeLaurier A., Ullmann B. et al. (2010) Modes of developmental outgrowth and shaping of a craniofacial bone in zebrafish. PLoS ONE 5, e9475.
13. Kitamura K., Takahira K., Inari M. et al. (2013) Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 166, 74-80.
14. Lindgren J.U., Johnell O. & DeLuca H.F. (1983) Studies of bone tissue in rats treated by prednisolone and 1, 25-(OH)2D3. Clin. Orthop. Relat. Res. 181, 264-268.
15. Manelli F. & Giustina A. (2000) Glucocorticoid-induced osteoporosis. Trends Endocrinol. Metab. 11, 79-85.
16. Maricic M. (2011) Update on glucocorticoid-induced osteoporosis. Rheum. Dis. Clin. North Am. 37, 415-431.
17. Mazziotti G., Angeli A., Bilezikian J.P. et al. (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol. Metab. 17, 144-149.
18. Metz J.R., de Vrieze E., Lock E.J. et al. (2012) Elasmoid scales of fishes as model in biomedical bone research. J. Appl. Ichthyol. 28, 382-387.
19. Pasqualetti S., Banfi G. & Mariotti M. (2012a) The zebrafish scale as model to study the bone mineralization process. J. Mol. Histol. 43, 589-595.
20. Pasqualetti S., Banfi G. & Mariotti M. (2012b) Osteoblast and osteoclast behavior in zebrafish cultured scales. Cell Tissue Res. 350, 69-75.
21. Pederson L., Ruan M., Westendorf J.J. et al. (2008) Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl Acad. Sci. USA, 105, 20764-20769.
22. Persson P., Takagi Y. & Bjornsson B. (1995) Tartrate resistant acid phosphatase as a marker for scale resorption in rainbow trout, Oncorhynchus mykiss: effects of estradiol-17a treatment and refeeding. Fish Physiol. Biochem. 14, 329-339.
23. Quarles L.D. (1992) Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation. Am. J. Physiol. 263, E136-E141.
24. Rogers M.J. (2004) From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif. Tissue Int. 75, 451-461.
25. Rubin J., Biskobing D.M., Jadhav L. et al. (1998) Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblats-like cells. Endocrinology 139, 1006-1012.
26. Saag K.G., Emkey R., Schnitzer T.J. et al. (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N. Engl. J. Med. 339, 292-299.
27. Scholz-Ahrens K.E., Delling G., Stampa B. et al. (2007) Glucocorticosteroid-induced osteoporosis in adult primiparous Gottingen miniature pigs: effects on bone mineral and mineral metabolism. Am. J. Physiol. Endocrinol. Metab. 293, E385-E395.
28. Sire J.Y. & Akimenko M.A. (2004) Scale development in fish: a review, with description of sonic hedgehog (shh) expression in the zebrafish (Danio rerio). Int. J. Dev. Biol. 48, 233-247.
29. Suzuki N., Suzuki T. & Kurokawa T. (2000) Suppression of osteoclastic activities by calcitonin in the scales of goldfish (freshwater teleost) and nibbler fish (seawater teleost). Peptides 21, 115-124.
30. Suzuki N., Somei M., Seki A. et al. (2008) Novel bromomelatonin derivatives as potentially effective drugs to treat bone diseases. J. Pineal Res. 45, 229-234.
31. Suzuki N., Hayakawa K., Kameda T. et al. (2009) Monohydroxylated polycyclic aromatic hydrocarbons inhibit both osteoclastic and osteoblastic activities in teleost scales. Life Sci. 84, 482-488.
32. Weinstein R.S., Jilka R.L., Parfitt A.M. et al. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274-282.
33. Witten P.E., Huysseune A. (2009) A comparative view on mechanisms and functions of skeletal remodelling in teleost fish, with special emphasis on osteoclasts and their function. Biol Rev Camb Philos Soc. 84(2):315-346.